September 17, 2014 6:23 AM ET

Pharmaceuticals

Company Overview of Arginox Pharmaceuticals, Inc.

Executive Profile

Kenneth Drazan M.D.

Chief Executive Officer and Director, Arginox Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 3 different industries.

See Board Relationships
----

Background

Dr. Kenneth Drazan, Ken, is a Chief Executive Officer at Arginox Pharmaceuticals. He is a Co-Founder and Operating Partner at Bertram Capital Management LLC. Dr. Drazan oversees healthcare investments at the firm. He is a Board Certified liver transplant surgeon. Previously, Dr. Drazan was a life science executive and co-founder of several life science drug discovery companies. Earlier in his career, he was a leading academic liver transplant surgeon and basic scientist ...

Corporate Headquarters

3 Lagoon Drive
Redwood City, California 94065

United States

Phone: 888-274-6070
Fax: 650-517-0101

Board Members Memberships

Chief Executive Officer and Director
Chairman
Director

Education

MD
State University of New York
BA
Yale University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Arginox Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.